Skip to main content

Table 6 Patients with adolescent-adult neurological onset

From: Observational cohort study of the natural history of Niemann-Pick disease type C in the UK: a 5-year update from the UK clinical database

Patient number/Gender

Sibship

Date of birth

Age at diagnosis

Age at last FU (y, m)/deathc

Neonatal LD

HS/S

Seizures/cataplexy

VSGP

Dev. delay/cognitive problems

Ataxia

Swallowing problems

Psychiatric disturbance

Slurred speech

Miglustat?

Age at 1st miglustat start

Miglustat duration

Genetic mutations

108b/M

m

1976

23y

39y

PJ

No

No

17y

17y

25y

25y

No

Yes

Yes

32y

3y

c.3182 T > C(p.Ile1061Thr)/c.3019C > G(p.Pro1007Ala)

109/F

–

1975

18y

30yc

No

No

E 18y 6 m

18y

15y

15y

24y

18y

Yes

No

–

–

c.3182 T > C(p.Ile1061Thr)/c.3019C > G(p.Pro1007Ala)

11/M

–

1978

20y

27y 3 mc

No

No

No

<24y

<20y

No

23y

Yes

–

No

–

–

–

111/F

–

1975

25y 6 m

30yc

No

No

C 25y

25y

16y

24y

23y

No

23y

No

–

–

–

112/M

n

1971

24y

40y 2 m

No

No

No

16y

24y

<24y

No

29y

32y

No

–

–

c.3182 T > C(p.Ile1061Thr)/?

113/M

p

1968

19y

43y 2 mc

No

S 18y

E 17y

25y

18y

18y

25y

17y

18y

No

–

–

c.1843C > T(p.Arg615Cys)/c.3289-3291del(p.Asp1097del)

114a/M

–

1987

22y

24y 11 m

No

No

No

22y

15y

15y

23y

No

18y

Yes

24y

0.5y

–

115/M

p

1969

18y

28y 8 mc

No

S 1y 4 m

No

Yes

Yes

Yes

25y

28y

Yes

No

–

–

c.1843C > T(p.Arg615Cys)/c.3289-3291del(p.Asp1097del)

116/F

–

1963

38y

48y 6 m

No

No

No

<34y

37y

34y

39y

No

34y

Yes

39ye

–

c.1133 T > C(p.Val378Ala)/c.422_423dup(p.Lys142X)

117a/F

o

1978

25y

33y 11 m

No

No

No

No

25y

25y

32y

No

32y

Yes

29y

4y

c.1552C > T(p.Arg518Trp)/c.1552C > T(p.Arg518Trp)

118/M

–

–

27y

35y 4 m

–

Yes

Teens

No

Yes

Yes

Yes

20s

Yes

No

–

–

–

119d/F

–

1966

32y

42y

No

No

No

Yes

<18y

29y

38y

No

38y

Yes

37y

8

c.3182 T > C(p.Ile1061Thr)/?

120/M

–

1972

29y

39y 10 mc

–

–

–

–

Yes

–

–

–

–

No

–

–

–

121a/M

–

1982

20y

29y 2 m

No

No

No

–

Yes

–

–

–

Yes

No

–

–

–

122/M

–

1964

31y

48y 6 m

No

Yes

No

Yes

46y

No

Yes

No

No

Yes

42y

5y

–

123a/M

q

1967

40y

44y 5 m

–

No

Tremor

<40y

<40y

<40y

No

No

No

Yes

43y

1y

c.1408G > C(p .Ala 470 Pro/c.1816G > C (p.Glu608Gln)

124/F

–

1961

49y

50y 11 m

No

No

No

46y

42y

42y

49y

40y

42y

Yes

49y

1y

c.2000C > G(p.Ser667Trp)/?

125/F

r

1981

29y

30y 3 mc

No

20y

No

20s

20s

20s

20s

Teens

20s

–

–

–

c.2764C > T(p.Gln922X)/c.1133 T > C(p.Val378Ala)

126/M

r

1985

25y

26y 8 m

No

No

No

25y

Mild 25y

No

No

No

No

Yes

25y

1y

c.2764C > T(p.Gln922X)/c.1133 T > C(p.Val378Ala)

127/M

–

1969

42y

42y 6 m

–

No

Tremor (20s)

<34y

<34y

Yes

40y

No

Yes

No

43y

–

c.2903A > G(p.Asn968Ser)/c.3182 T > C(p.Ile1061Thr)

128/F

–

1954

49y 6 m

57y 6 m

No

No

No

Yes

Yes

20s

No

No

20s

No

–

–

c.3182 T > C(p.Ile1061Thr)/?

129/F

–

–

PM

40yc

–

–

–

–

–

–

–

–

–

–

–

–

c.3182 T > C(p.Ile1061Thr)/c.2861C > T(p.Ser954Leu)

130/M

q

–

40y

41y 9 m

–

40y

Tremor (35y)

Yes

No

Yes

40y

No

No

Yes

39y

–

c.1408G > C(p .Ala 470 Pro/c.1816G > C (p.Glu608Gln)

131/F

–

–

27y

27y 8 m

No

No

No

No

No

25y

No

27y

No

No

–

–

c.3022A > C p (Asn 1008 His)/c.3182 T > C p.(Ile 1061Thr)

132a/M

s

1974

Early 30s

–

–

–

–

–

20y

–

–

–

–

Yes

–

–

c.2336del (p.Phe779SerfsX2)/c.2621A > T(p.Asp874Val)

  1. aPatients included in previously reported NPC Registry baseline characteristics study [11]; bPatients included in previously reported NPC Registry baseline and longitudinal data study [11, 12]; cpatient died; dpatient 119 F previously subject of case report by Lachmann et al. [10]; etreatment interrupted (first treatment start at 39 y, second treatment start at 46 y); ‘–’, no data/not known; C cataplexy, E epilepsy, FA foetal ascites, HM hepatomegaly, HS/S hepatosplenomegaly/splenomegaly, LD liver disease, LTx liver transplant, m months, NC neonatal cholestasis, PJ prolonged jaundice, PM post mortem, y years, w weeks